慢性稳定型冠心病的核素心肌灌注显像临床应用进展

李殿富

李殿富

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 3: (97-100)

引用本文:

Citation:

慢性稳定型冠心病的核素心肌灌注显像临床应用进展

李殿富

210029 南京, 南京医科大学第一附属医院心脏科核心脏病学研究室
中图分类号: R817.4

Clinical progress of myocardial perfusion imaging in stable coronary artery disease

LI Dian-fu

Department of Nuclear Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China
CLC number: R817.4

摘要: 多项临床试验证明,核素心肌灌注显像在冠心病诊断、危险度分层、预后判断、病人处理方案等方面具有突出的作用和优越的价值。在ACC/AHA(美国心脏病学院/美国心脏学会)有关冠心病和核心脏病学指南中,心肌灌注显像的上述作用得到了充分肯定。合理应用该项技术可以提高对冠心病诊断、处理的整体水平,并使有限的医疗资源得到更合理利用,这在我国目前显得十分迫切和需要。
- 冠心病 /
- 心肌灌注显像 /
- 危险度分层 /
- 预后
Abstract: Many clinical trials have proven nuclear myocardial perfusion imaging may take a key role in diagnoses, risk stratification and management of coronary artery disease. These values of myocardial perfusion imaging have been stressed in the guidelines of ACC/AHA about coronary artery disease and nuclear cardiology. The appropreciate use of myocardial perfusion imaging may increase our ability of managing with coronary disease and better utilization of medical resources in China.
- coronary artery disease /
- myocardial perfusion imaging /
- risk stratification /
- prognosis
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Berman DS, Hayes SW, Shaw LJ, et al. Recent advances in myocardial perfusion imaging[J]. Curr Pro Cardiol, 2001,26:8-112.
[2]	Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease:a basis for optimal untilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission commputed tomography[J].J Am Coll Cardiol, 1995,26:639-647.
[3]	Hachamovitch R, Berman DS, Kiat H, et all. Exercise myocardial perfusion SPECT in patients without known coronary artery disease:incrementalprognostic value and use in risk stratification[J]. Circulation, 1996, 93:905-914.
[4]	He ZX, Shi RF, Wu YJ, et al. Direct imaging of exercise induced myocardial ischemia with fluorine labeled deoxyglucose and Tc-99m sestamibi in coronary artery disease[J]. Circulation, 2003, 108:1208-1213.
[5]	Vourvori EC, Poldermans D, Bax J J, et al. Evaluation of left ventrcular function and volumes in patients with ischaemic cardiomyocpathy:Gated single-photon emission computed tomography versus two-dimensional echocardiography[J].EurJ Nucl Med, 2001, 28:1610.
[6]	Raymond J, Jonathan A, Kanu C, et al. ACC/AHA 2002guideline update for the management of patients with chronic stable angina[J]. Circulation, 2003, 107:149-158.
[7]	Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging, executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for Clinical Use of Cardiac Radionuclide Inaging)[J].Circulation, 2003,108:1404-1418.
[8]	Papaioannou Gl, Heller GV. Known coronary artery disease[A]. Heller GV, eds. Nuclear Cardiology[M]. New York:McGraw-Hill, 2004. 21-28.
[9]	Hachamovitch R, Berman DS, Shaw LJ. et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death:differential stratification for risk of cardiac death and myocardial infarction[J].Circulation, 1998,97:535-543.
[10]	Emmett L, Iwanochko RM, Freeman MR, et aL Reversible regional wall motion abnormalities on exercise technetium 99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses[J]. J Am Coll Cardiol, 2002, 39:991-998.
[11]	Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients:an observational assessment of the value of precatheterization ischemia[J]. J Am Coll Cardiol,1999,33:661-669.
[12]	Yamagishi H, Shirai N, Yoshiyama M, et al. Incremental value of left ventricular ejection fraction for detection of multivessel coronary artery disease in exercise(201)Tl gated myocardial perfusion imaging[J]. J Nucl Med, 2002, 43:131.
[13]	Hachamovitch R, Berman D, Lewin H, et al. Incremental prognostic value of gated SPECT ejection fraction in patients undergoing dual-isotope exercise or adenosine stress SPECT[J]. J Am Coll Cardiol, 1998, 31:441A.
[14]	Sharir T, Gemano G, Lewin HC, et al. Prognostic value of myocardial perfusion and function by gated SPECT in the prediction of non-fatal myocardial infarction and cardiac death[J]. Circulation, 1999, 100:I-383.
[15]	Lima RSL, Watson DD, Goode AR, et al. Incrememtal value ofcombined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease[J]. J Am Coll Cardiol, 2003, 42(1):64-70.
[16]	Sharir T, Bacher-Stier C, Dhar S, et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography[J]. Am J Cardiol, 2000, 86:1171-1175.
[17]	Wackers TH, Zaret BL. Nuclear Cardiology[A]. Braunwald E, eds. Heart Diease[M]. Ed6. Philadelphia:Saunders,2001. 273-297.

[1]	李殿富 . 核素心肌显像在冠心病处理决策中的合理应用及其原理. 国际放射医学核医学杂志, 2004, 28(2): 56-59.
[2]	李胜亭 , 刘秀杰 . 心肌显像估测冠心病预后的价值. 国际放射医学核医学杂志, 1996, 20(1): 4-8.
[3]	陈小明 . SPECT在冠心病危险度分层方面的应用. 国际放射医学核医学杂志, 2004, 28(3): 101-105.
[4]	郭小闪 , 靳春荣 , 武志芳 , 武萍 , 李莉 , 陈伟强 , 李思进 . 瑞加诺生负荷心肌灌注显像诊断冠心病的初步临床研究. 国际放射医学核医学杂志, 2020, 44(10): 634-640. doi: 10.3760/cma.j.cn121381-202003048-00088
[5]	张建萍 , 刘雪辉 , 于泓煦 , 刘娜 , 沈慧 , 陈兵 . 心肌灌注显像引导下行PCI治疗的Graves甲亢合并冠心病一例. 国际放射医学核医学杂志, 2019, 43(6): 589-592. doi: 10.3760/cma.j.issn.1673-4114.2019.06.016
[6]	孙璐冰 , 阮翘 . 心肌灌注显像联合冠状动脉钙化积分诊断冠心病的价值及最新进展. 国际放射医学核医学杂志, 2017, 41(2): 143-149. doi: 10.3760/cma.j.issn.1673-4114.2017.02.012
[7]	张科 , 谭红霞 , 宋波 . ⁹⁹Tc^m-MIBI心肌灌注显像对行PCI术的冠心病患者中的近期效果的评估作用. 国际放射医学核医学杂志, 2019, 43(5): 422-426. doi: 10.3760/cma.j.issn.1673-4114.2019.05.007
[8]	李琳琳 , 庞泽堃 , 陈越 , 汪娇 , 李剑明 . 碲锌镉心脏专用SPECT动态心肌灌注显像定量参数在INOCA和OCAD患者预后评估中的诊断价值. 国际放射医学核医学杂志, 2024, 48(1): 5-14. doi: 10.3760/cma.j.cn121381-202307008-00383
[9]	郑丹栅 , 兰晓莉 , 覃春霞 . 门控心肌灌注显像相位分析及其临床应用进展. 国际放射医学核医学杂志, 2021, 45(7): 443-448. doi: 10.3760/cma.j.cn121381-202006012-00060
[10]	薛倩倩 , 姚稚明 . 冠状动脉钙化积分、心肌灌注显像及其联合应用的临床价值. 国际放射医学核医学杂志, 2013, 37(5): 301-305. doi: 10.3760/cma.j.issn.1673-4114.2013.05.012
[11]	刘纯 , 刘秀杰 . ^99mTc-MIBI心肌灌注显像的临床应用. 国际放射医学核医学杂志, 1996, 20(1): 14-16.

点击查看大图

计量

文章访问数: 1479
HTML全文浏览量: 160
PDF下载量: 3

慢性稳定型冠心病的核素心肌灌注显像临床应用进展

李殿富

210029 南京, 南京医科大学第一附属医院心脏科核心脏病学研究室

收稿日期: 2004-03-04

关键词:

摘要: 多项临床试验证明,核素心肌灌注显像在冠心病诊断、危险度分层、预后判断、病人处理方案等方面具有突出的作用和优越的价值。在ACC/AHA(美国心脏病学院/美国心脏学会)有关冠心病和核心脏病学指南中,心肌灌注显像的上述作用得到了充分肯定。合理应用该项技术可以提高对冠心病诊断、处理的整体水平,并使有限的医疗资源得到更合理利用,这在我国目前显得十分迫切和需要。